Notification of Major Interest in Mediclinic International plc shares Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 8 May 2018 Notification of Major Interest in Mediclinic International plc shares 1a. Identity of the issuer or the underlying issuer Mediclinic International plc. of existing shares to which voting rights are attached(ii): 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify)iii: 3. Details of person subject to the notification obligation Coronation Asset Management (Pty) Ltd acting as discretionary Name investment manager on behalf of managed portfolios. City and country of registered office (if applicable) Cape Town, South Africa 4. Full name of shareholder(s) (if different from 3.)(v) Name N/A City and country of registered office (if applicable) 5. Date on which the threshold was crossed or reached(vi): 7 May 2018 6. Date on which issuer notified (DD/MM/YYYY): 7 May 2018 7. Total positions of person(s) subject to the notification obligation % of voting rights % of voting rights through financial Total number of attached to shares instruments Total of both in % voting rights of (total of 8. A) (total of 8.B 1 + 8.B 2) (8.A + 8.B) issuer(vii) Resulting situation on the date on which 4.92% 4.92% 737 243 810 threshold was crossed or reached Position of previous notification (if 5.01% 5.01% applicable) 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii) A: Voting rights attached to shares Class/type of Number of voting rights(ix) % of voting rights shares ISIN code (if possible) Direct Indirect Direct Indirect (Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive 2004/109/EC) (DTR5.1) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.2.1) (DTR5.2.1) GB00B8HX8Z88 36 248 868 4.92% SUBTOTAL 8. A 36 248 868 4.92% B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Number of voting rights Type of financial Expiration Exercise/ that may be acquired if instrument date(x) Conversion Period(xi) the instrument is % of voting rights exercised/converted. SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Exercise/ Physical or Type of financial Expiration Conversion cash Number of instrument date(x) Period (xi) settlement(xii) voting rights % of voting rights SUBTOTAL 8.B.2 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity xiv X (please add additional rows as necessary) % of voting rights % of voting rights through financial Total of both if it if it equals or is instruments if it equals or is higher Name(xv) higher than the equals or is higher than the notifiable notifiable threshold than the notifiable threshold threshold Coronation Fund Managers Ltd Coronation Investment Management SA (Pty) Ltd Coronation Asset Management (Pty) Ltd 4.92% 4.92% 10. In case of proxy voting, please identify: Name of the proxy holder Coronation Asset Management (Pty) Ltd The number and % of voting rights held The date until which the voting rights will be held 11. Additional information(xvi) Name: Stephan Kemp Email: skemp@coronation.co.za Telephone: +27 21 680 2000 Place of completion Cape Town, South Africa Date of completion 7 May 2018 Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. For further information, please contact: Company Secretary, Link Company Matters Limited Jayne Meacham / Caroline Emmet +44 (0)20 7954 9569 Investor Relations, Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com +44 (0)20 3786 8181 Media queries FTI Consulting Brett Pollard/Debbie Scott – UK +44 (0)20 3727 1000 Sherryn Schooling – South Africa +27 (0)21 487 9000 Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom Website: www.mediclinic.com Corporate broker: Morgan Stanley & Co International plc JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd Date: 08/05/2018 11:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.